National Lab Briefs

Argonne Reactor Program Turns To The East Faced with dwindling U.S. interest in nuclear power research, Argonne National Lab has turned to Japan to save its reactor research program. In July the lab reached an agreement with the Japanese electric industry that will see $20 million over five years poured into a lab program on “pyrometallurgical” fuel reprocessing. The technique separates radioactive elements from used fuel for recasting into new fuel, thereby allowing the reactor to


Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Faced with dwindling U.S. interest in nuclear power research, Argonne National Lab has turned to Japan to save its reactor research program. In July the lab reached an agreement with the Japanese electric industry that will see $20 million over five years poured into a lab program on “pyrometallurgical” fuel reprocessing. The technique separates radioactive elements from used fuel for recasting into new fuel, thereby allowing the reactor to bum its own waste. But the process is at least a decade away from commercial application, says Argonne project manager Yoon Chang, and the listless U.S. nuclear industry is “not looking at long-term energy policy.” The Japanese involvement comes as Congress threatens to cut funding for Argonne’s entire Integral Fast Reactor program to as little as a third of the $30 million the Department of Energy requested in its 1990 budget.

“Without the Japanese [investment] we would have had problems supporting ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide